Inline Bioaerosol Reduction Testing

Purpose & when to use

Inline Bioaerosol Reduction testing measures how much microbial aerosol an in-duct, enclosed-flow, or device-mounted treatment system removes in a single pass under defined flow and load conditions. Studies use controlled duct sections, bioaerosol generation, viable samplers, filter trains, airflow logging, and culture, qPCR, or droplet digital PCR (ddPCR) endpoints to support ISO 17025 records and ASHRAE 241-aligned reduction metrics:

In-duct HVAC air-cleaner comparison under ASHRAE 241 context, using defined flow, upstream/downstream samplers, and device-off baselines for single-pass reduction.
UVGI or active-treatment module verification for building ventilation systems, using ASHRAE 62.1 airflow context, UV or mode logs, and viable recovery.
Inline medical or scavenging interface screening under ISO 17025 controls, using sealed adapters, bioaerosol load control, and qPCR or ddPCR endpoint quantitation.
ISO 16000 indoor-air duct studies for air-treatment products, using defined injection, downstream sampling, RH and temperature logging, and replicate condition blocks.
EPA antimicrobial product performance support for air-treatment claims, using organism selection, device-off controls, recovery checks, and reduction metrics matched to claim language.

Use inline bioaerosol reduction testing when the decision depends on how much microbial aerosol a device removes in one pass through a defined flow path. Before testing begins, the protocol fixes the flow, load, sampling interval, endpoint, and alignment frame.

Built for inline and ducted air-treatment devices

Inline bioaerosol reduction studies serve products where airflow path, mounting geometry, and device mode determine the microbial reduction result under ASHRAE, ISO, or EPA claim frames.

Duct unitsInstalled HVAC treatment modules
UVGI modulesInline ultraviolet treatment
Air cleanersDucted and hybrid systems
Scavenging interfacesEnclosed clinical flow paths
Control systemsMode and fan logic

Instrumentation & measurement ranges

We select the test platform based on the flow path, organism or surrogate, endpoint sensitivity, and device operating mode.

10 - 1000 L/minchallenge-flow

Inline duct sections and adapters

Duct sections, sealed adapters, and mounting fixtures define upstream injection, downstream sampling, bypass control, and device-under-test placement.

0.1 - 10 mL/minliquid-feed

Bioaerosol generators and load control

Nebulizers or protocol-specific generators introduce organism or surrogate loads at defined release rates with pre-run background checks.

1 - 30 L/minsampler-flow

Viable samplers and molecular collection

Impingers, filter holders, and timed collection trains capture upstream and downstream bioaerosol samples for interval-by-interval reduction calculations.

10 - 10000000 copiesquantitation

Culture, qPCR, and ddPCR endpoints

Culture and molecular assays convert collected material into viable counts, gene copies, or absolute copy number depending on organism and study objective.

20 - 80 RHcondition-control

Flow and environmental logging

Flow, RH, temperature, device speed, duty cycle, and UV or active-treatment settings are logged through every baseline and device-on run.

Test method options

Method	Strengths	Tradeoff	Aligned with
ASHRAE 241 aligned inline reduction study	Connects upstream/downstream bioaerosol recovery to infectious aerosol control and equivalent clean airflow concepts for in-duct air-treatment devices. Device-off baselines and interval sampling distinguish treatment effect from line loss, natural decay, and sampler recovery behavior.	Flow uniformity, challenge stability, and repeated baseline runs must be controlled before single-pass reduction values are comparable.	ASHRAE 241ISO 17025
Ventilation-system inline mapping study	Uses ASHRAE 62.1 airflow context and ISO 16000-36 aligned sampling logic to compare duct devices, UVGI modules, and hybrid systems. Multi-speed and duty-cycle mapping identifies best-case, worst-case, and normal operating points using the same upstream/downstream geometry.	Each fan speed, mode, or duty cycle adds replicate blocks, increasing run count and data-review time.	ASHRAE 62.1ISO 16000-36
EPA claim-support inline screening	Frames organism selection, controls, and reduction outputs for EPA antimicrobial product performance discussions when air-treatment claim language requires support. Fit-for-purpose endpoint selection allows culture, qPCR, or ddPCR reporting based on viability needs, biosafety limits, and product mechanism.	Claim fit depends on organism, exposure time, device geometry, and whether single-pass reduction is the right evidence for the label.	EPA antimicrobial product performanceISO 17025

Setup configurations

Each inline study begins with the device geometry, flow setpoint, challenge organism or surrogate, and intended claim frame. This configuration determines how we document the upstream load, downstream recovery, bypass control, environmental drift, and device operating mode before the first reduction run. The protocol fixes these setup dimensions:

Device interfaces

Duct insertion, sealed adapter, tube section, or clinical interface mounting documented with photographs, seals, bypass checks, and sampling-port locations.

Flow & actuation profiles

Volumetric flow, fan speed, duty cycle, treatment mode, UV setting, and stabilization period defined for each condition.

Exposure profile

Upstream injection location, challenge load, sampling interval, device-on timing, and run duration matched to expected reduction.

Sample numbers

Replicate device-on runs, device-off baselines, blanks, and background checks sized to variability and the decision threshold.

Calibration & verification

Sampler flow, duct flow, environmental sensors, generator output, endpoint controls, and recovery checks verified within the study record.

Methods anchored to the standards that matter

Inline studies distinguish the accredited laboratory quality anchor from the aligned building, indoor-air, and method frames. The anchors below define the study records, flow controls, and reporting language.

ISO 17025AccreditedTesting-laboratory competence, traceable calibration, method records, and data review.
ASHRAE 241AlignedInfectious aerosol control and equivalent clean airflow context.
ASHRAE 62.1AlignedVentilation-system airflow and indoor air quality context.
ISO 16000-36AlignedIndoor-air chamber and microorganism reduction context.

Key data outputs & reporting

Inline bioaerosol reduction reports pair upstream and downstream microbial concentrations for each sampling interval and device condition. Outputs include single-pass reduction, device-off baselines, mode or speed comparisons, replicate statistics, endpoint recovery, flow and environmental logs, and QA/QC evidence. Together, these records help explain which product, building, or antimicrobial claim decisions the data can support under the tested conditions.

Primary outputs

Upstream and downstream concentration by sampling interval, endpoint, device mode, and replicate.
Single-pass percent reduction and optional CADR-like bioaerosol equivalent, with calculation basis stated as fit for purpose.
Device-off baseline and blank results used to separate treatment effect from duct loss, background, and sampler artifacts.
Flow, RH, temperature, UV or treatment settings, fan speed, and duty-cycle records tied to each run.

Deliverables

#	Format	Contents
01	PDF report	Methods, configuration, controls, reduction results, QA / QC, and study interpretation.
02	CSV / XLSX datasets	Interval concentrations, reductions, recovery checks, replicates, and environmental records.
03	Figures	Upstream/downstream comparisons, mode overlays, and reduction summaries by condition.

QA / QC & data integrity

Inline bioaerosol studies use controls to distinguish device reduction from duct loss, background contamination, sampler recovery, assay variability, and environmental drift. Records are maintained under the ISO 17025 quality system from organism receipt or preparation through final data review. This includes traceability for instruments, samples, endpoints, and calculations.

Device-off controls and background runs define baseline line loss and pre-challenge conditions.

Sampler blanks, media blanks, extraction controls, and assay controls track contamination and endpoint background.

Recovery checks for impingers, filters, extraction steps, and culture or molecular assays support quantitation limits.

Replicate runs and repeated sequences quantify variability across device speeds, modes, organisms, or flow setpoints.

Calibration records cover sampler flow, duct flow, RH, temperature, and UV or treatment instrumentation when used.

Chain of custody tracks organisms, devices, collected samples, extracts, and raw instrument files.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)

17025Accredited testing

900+Studies Performed

17+Years in operation

300+Clients supported

Common questions

These answers address common questions from HVAC engineers, air-treatment developers, UVGI teams, medical-device teams, and antimicrobial product groups planning inline bioaerosol reduction studies. Topics include single-pass calculations, device-off baselines, organism and surrogate selection, multi-speed mapping, CADR-like bioaerosol equivalents, and deliverables. Contact us if your flow path, device geometry, or claim frame differs from the examples below.

Q.How is inline reduction different from room efficacy?

A.Inline testing measures single-pass reduction across a defined flow path. Room efficacy testing measures concentration decay over time in a mixed volume. We select the setup based on whether the device operates in a duct, tube, interface, or open room.

Q.Do you provide CADR-like bioaerosol metrics?

A.Yes, when the calculation is fit for purpose. The report documents the flow basis, concentration inputs, controls, and assumptions so the CADR-like value is not mistaken for a result from a fixed AHAM method.

Q.Can you test multiple fan speeds or duty cycles?

A.Yes. Multi-speed and duty-cycle mapping is common for ducted devices. We test replicate condition blocks with device-off controls so each operating mode can be compared using the same baseline logic.

Q.Which endpoints can be used?

A.Culture, qPCR, and ddPCR endpoints are available based on the organism, viability question, biosafety limits, and expected reduction. Before testing begins, the protocol defines the recovery checks and quantitation limits.

Q.What do I receive after testing?

A.You receive a PDF report, CSV or XLSX datasets, and figures that present upstream and downstream concentrations, single-pass reduction, controls, recovery checks, flow records, environmental conditions, and study interpretation.

Standards & guidance

Each inline bioaerosol reduction study is scoped to the standard or guidance that fits the device, airflow path, organism, endpoint, and intended claim. ISO 17025 provides the accredited quality-system anchor. ASHRAE 241, ASHRAE 62.1, ISO 16000-36, and EPA antimicrobial product performance guidance are used as aligned frames when they fit the study design and reporting objective.

QA & Regulatory - Accredited

Related services & devices

Service

Inline Bioaerosol Reduction